SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041416
Filing Date
2023-08-10
Accepted
2023-08-10 16:33:32
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20230630.htm   iXBRL 10-Q 4010189
2 EX-10.1 stro-ex10_1.htm EX-10.1 864957
3 EX-10.2 stro-ex10_2.htm EX-10.2 125866
4 EX-31.1 stro-ex31_1.htm EX-31.1 19219
5 EX-31.2 stro-ex31_2.htm EX-31.2 19394
6 EX-32.1 stro-ex32_1.htm EX-32.1 9664
7 EX-32.2 stro-ex32_2.htm EX-32.2 9694
  Complete submission text file 0000950170-23-041416.txt   14661738

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20230630_pre.xml EX-101.PRE 466424
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20230630.xsd EX-101.SCH 81222
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stro-20230630_cal.xml EX-101.CAL 48990
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stro-20230630_def.xml EX-101.DEF 330424
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20230630_lab.xml EX-101.LAB 582665
72 EXTRACTED XBRL INSTANCE DOCUMENT stro-20230630_htm.xml XML 2828984
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 231160122
SIC: 2836 Biological Products, (No Diagnostic Substances)